MedPath

A clinical trial to study the effect of drug tranexamic acid in addition to oxytocin in reducing blood loss after vaginal delivery

Phase 4
Conditions
Health Condition 1: O720- Third-stage hemorrhage
Registration Number
CTRI/2023/09/057612
Lead Sponsor
PT J N M Medical College Raipur
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

WOMEN PLANNED FOR VAGINAL DELIVERY

Exclusion Criteria

AGE < 18 YEARS

Study & Design

Study Type
PMS
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Blood loss after vaginal deliveryTimepoint: Within 1 hour after vaginal delivery
Secondary Outcome Measures
NameTimeMethod
Haemoglobin levelTimepoint: After 24 hours of vaginal delivery
© Copyright 2025. All Rights Reserved by MedPath